93
Views
0
CrossRef citations to date
0
Altmetric
Review

A systematic review of the bioprospecting potential of Lonomia spp. (Lepidoptera: Saturniidae)

ORCID Icon & ORCID Icon
Pages 583-598 | Received 22 Apr 2022, Accepted 14 Apr 2023, Published online: 02 May 2023

References

  • Abella, H., et al., 1999. Manual de diagnóstico – tratamento de acidentes por lonomia. Porto Alegre, Brazil: Governo do Estado do Rio Grande do Sul. Secretria de Saúde. Fundação Estadual de Produção e Pesquisa em Saúde.
  • Aguilar, I., et al., 2014. Coral snake antivenom produced in chickens (Gallus domesticus). Revista do Instituto de Medicina Tropical de Sao Paulo, 56 (1), 61–66.
  • Alvarenga, L.M., et al., 2014. Engineering venom’s toxin-neutralizing antibody fragments and its therapeutic potential. Toxins, 6 (8), 2541–2567.
  • Alvarenga, Z., 1912. Taturana. In: Anais do VIII congresso Brasileiro de medicina cirúrgica. Belo Horizonte, Brazil: A Taturana, 132–135.
  • Alvarez-Flores, M.P., et al., 2006. Losac, a factor X activator from Lonomia obliqua bristle extract: its role in the pathophysiological mechanisms and cell survival. Biochemical and biophysical research communications, 343 (4), 1216–1223.
  • Alvarez-Flores, M.P., et al., 2011. Losac, the first hemolin that exhibits procogulant activity through selective factor X proteolytic activation. The journal of biological chemistry, 286 (9), 6918–6928.
  • Alvarez-Flores, M.P., et al., 2019. Neuroprotective effect of rLosac on supplement-deprived mouse cultured cortical neurons involves maintenance of monocarboxylate transporter MCT2 protein levels. Journal of neurochemistry, 148 (1), 80–96.
  • Alvarez-Flores, M.P., et al., 2012. Mechanisms implicated in cell proliferation and cell survival induced by recombinant losac, a cell adhesion molecule from Lonomia oblique. Toxicon, 60 (2), 142–143.
  • Andrade, R.D.O., 2017. Espinhos repletos de veneno. Revista Pesquisa FAPESP, 62–63.
  • Andrade, S.A., et al., 2012. Reversal of the anticoagulant and anti-hemostatic effect of low molecular weight heparin by direct prothrombin activation. Brazilian journal of medical and biological research, 45 (10), 929–934.
  • Angelo, M., 2017. Casanare epicentro de los accidentes con oruga lonomia. Yopal, Colombia: Prensa Libre Casanare.
  • Araújo, A.S., et al., 2010. Brazilian IgY-Bothrops antivenom: studies on the development of a process in chicken egg yolk. Toxicon, 55 (4), 739–744.
  • Arias, E., 2019. Antiveneno lonómico polivalente. Biomédica, 39 (3), 38–39.
  • Arocha-Piñango, C.L., 1967. Fibrinolisis producida por contacto con orugas : comunicación preliminar. Acta Cientifica Venezolana, 18 (5), 136–139.
  • Arsanios, D.M., et al., 2020. Acute kidney injury secondary to Lonomia envenomation. Case report and literature review, 61 (2), 72–85.
  • Bernardi, L., et al., 2019. Lonomia obliqua bristle extract modulates Rac1 activation, membrane dynamics and cell adhesion properties. Toxicon, 162, 32–39.
  • Bordon, K.C.F., et al., 2020. From animal poisons and venoms to medicines: achievements, challenges and perspectives in drug discovery. Frontiers in pharmacology, 11, 1132.
  • Bosch, R.V., et al., 2016. Hemolin triggers cell survival on fibroblasts in response to serum deprivation by inhibition of apoptosis. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie, 82, 537–546.
  • Brechlin, R., 2017. Sechs neue arten der gattung Lonomia walker, 1855 (Lepidoptera: Sarurniidae). Entomo-Satsphingia, 10 (1), 22–31.
  • Camargo, A.C., et al., 2012. Bradykinin-potentiating peptides: Beyond captopril. Toxicon, 59 (4), 516–523. 10.1016/j.toxicon.2011.07.013
  • Caovilla, J.J., and Barros, E.J., 2004. Efficacy of two different doses of antilonomic serum in the resolution of hemorrhagic syndrome resulting from envenoming by Lonomia obliqua caterpillars: a randomized controlled trial. Toxicon, 43 (7), 811–818.
  • Carmo, A.C., et al., 2012. Expression of an antiviral protein from Lonomia obliqua hemolymph in baculovirus/insect cell system. Antiviral research, 94 (2), 126–130.
  • Carmo, A.C., et al., 2015. Discovery of a new antiviral protein isolated Lonomia obliqua analysed by bioinformatics and real-time approaches. Cytotechnology, 67 (6), 1011–1022.
  • Carrijo-Carvalho, L.C., and Chudzinski-Tavassi, A.M., 2007. The venom of the Lonomia caterpillar: an overview. Toxicon, 49 (6), 741–757.
  • Chudzinski-Tavassi, A., Carrijo-Carvalho, L., et al., 2010. Procoagulant factors from Lonomia caterpillars. In: R.M. Kini ed. Toxins and hemostasis. Dordrecht, Netherlands: Springer, 559–574.
  • Chudzinski-Tavassi, A., and Zannin, M., 2011. Aspectos clínicos y epidemiológicos del envenenamiento por Lonomia obliqua. In: G. D’Suze, G. Burguete, and J. Solís, eds. Emergenciais por animales ponzoñosos en las Américas. Ciudad de México: Instituto Bioclon, 303–321.
  • Chudzinski-Tavassi, A.M., et al., 2010. A lipocalin sequence signature modulates cell survival. FEBS letters, 584 (13), 2896–2900.
  • Coll-Sangrona, E., and Arocha-Piñango, C.L., 1998. Fibrinolytic action on fresh human clots of whole body extracts and two semipurified fractions from Lonomia achelous caterpillar. Brazilian journal of medical and biological research, 31 (6), 779–784.
  • Correa, O., 2018. Entregan recomendaciones para no tener accidentes con la oruga venenosa en Yopal. El Diario del Llano, 13 Sep.
  • Cushman, D.W., et al., 1977. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry, 16 (25), 5484–5491. 10.1021/bi00644a014
  • Da Silva, S.L., et al., 2014. Animal Toxins and Their Advantages in Biotechnology and Pharmacology. BioMed Research International, 2014, 1–2. 10.1155/2014/951561
  • Da Silva, W.D., 2003. Development and clinical use of antilonomic serum. Journal of toxicology, 22 (1), 61–68.
  • Da Silva, W.D., et al., 1996a. Development of an antivenom against toxins of Lonomia obliqua caterpillars. Toxicon, 34 (9), 1045–1049.
  • Da Silva, W.D., et al., 1996b. Anti-lonomia serum: an antivenom produced to neutralize the hemorrhagic disorder induced by a caterpillar toxin. Toxicon, 34 (1), 18.
  • De Roodt, A., Salomon, O., and Orduna, T., 2000. Accidentes por lepidopteros con especial referencia a Lonomia sp. Medicina, 60 (6), 964–972.
  • Do Nascimento, S., et al., 2016. A new lysozyme found in the haemolymph from pupae of Lonomia obliqua (Lepidoptera: Saturniidae). Trends in antomology, 12, 13–23.
  • Dos Anjos, I., 2019. Caracterização biológica do extrato de cerdas de Lonomia descimoni (Lepidópteros, Saturniidae) e eficácia da soroterapia no envenenamento experimental. São Paulo, Brazil: Secretaia de Estado da Saúde de São Paulo.
  • El Pilón., 2018. Alarma en el Cesar por caso confirmado de oruga venenosa. El Pilón, 3 Dec, pp. 1–5.
  • Ferreira, S.H., and Rocha e Silva, M., 1965. Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) fromBothrops jararaca venom. Experientia, 21 (6), 347–349. 10.1007/BF02144709
  • Ferreira, S.H., et al., 1970. Activity of Various Fractions of Bradykinin Potentiating Factor against Angiotensin I Converting Enzyme. Nature, 225 (5230), 379–380. 10.1038/225379a0
  • Ferreira Junior, R.S., et al., 2010. New nanostructured silica adjuvant (SBA-15) employed to produce antivenom in young sheep using Crotalus durissus terrificus and Apis mellifera venoms detoxified by cobalt-60. Journal of toxicology and environmental health, Part A, 73 (13–14), 926–933.
  • Fritzen, M., et al., 2005. A prothrombin activator (Lopap) modulating inflammation, coagulation and cell survival mechanisms. Biochemical and biophysical research communications, 333 (2), 517–523.
  • FUNASA., 2001. Manual de diagnóstico e tratamento de acidentes por animais peçonhentos. Brasília, Brazil: FUNASA.
  • Gamborgi, G.P., et al., 2012. Influência dos fatores abióticos sobre casos de acidentes provocados por Lonomia obliqua. Hygeia – Revista Brasileira de Geografia Médica e da Saúde, 8 (14), 201–208.
  • Garcia, C., 2017. Analytical test on the environmental constraints related to accidents with the Lonomia obliqua walker 1855, in Southern Brazil. Journal of ecosystem & ecography, 3 (3), 125.
  • Gonçalves, L.R., et al., 2007. Efficacy of serum therapy on the treatment of rats experimentally envenomed by bristle extract of the caterpillar Lonomia obliqua: comparison with epsilon-aminocaproic acid therapy. Toxicon, 50 (3), 349–356.
  • Gouveia, A.I.D.C.B., 2004. Bioprospecção de toxinas presentes na hemolinfa e extrato de cerdas da lagarta Lonomia obliqua. Master’s thesis. Repositório Institucional – Rede Paraná Acervo.
  • Greco, K.N., et al., 2009. Antiviral activity of the hemolymph of Lonomia obliqua (Lepidoptera: Saturniidae). Antiviral research, 84 (1), 84–90.
  • Grimaldi, D., and Engel, M. S., Evolution of the Insects (1st ed., p. 772)., Cambridge University Press 2005. 772, 1st Ed., Diversity and Evolution.
  • Guerrero, B., et al., 2001. Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model. Blood coagulation & fibrinolysis, 12 (7), 521–529.
  • Guerrero, B., et al., 2011. The effects of Lonomin V, a toxin from the caterpillar (Lonomia achelous), on hemostasis parameters as measured by platelet function. Toxicon, 58 (4), 293–303.
  • Guerrero, B., et al., 1999. Effect on platelet FXIII and partial characterization of Lonomin V, a proteolytic enzyme from Lonomia achelous caterpillars. Thrombosis research, 93 (5), 243–252.
  • Guerrero, B., and Arocha-Piñango, C.L., 1992. Activation of human prothrombin by the venom of (Cramer) caterpillars. Thrombosis research, 66 (2–3), 169–177.
  • Guerrero, B.A., Arocha-Piñango, C.L., and Juan, A.G.A., 1997. Degradation of human factor XIII by Lonomin V, a purified fraction of Lonomia achelous caterpillar venom. Thrombosis research, 87 (2), 171–181.
  • Hayashida, P.Y., Da Silva Junior, P.I., and Mendonça, R.Z., 2019. Lonomia obliqua’s hemolymph: new horizons to antibiotics. Toxicon, 168, S28–S29.
  • Heinen, T.E., and Da Veiga, A.B., 2011. Arthropod venoms and cancer. Toxicon, 57 (4), 497–511.
  • Heinen, T.E., et al., 2014. Effects of Lonomia obliqua caterpillar venom upon the proliferation and viability of cell lines. Cytotechnology, 66 (1), 63–74.
  • Instituto Nacional de Salud., 2019. INS Colombia realizó su rendición de cuentas vigencia 2019. Available from: https://www.ins.gov.co/Noticias/Paginas/INS-Colombia-realizó-su-Rendición-de-Cuentas-vigencia-2019-.aspx [Accessed 18 May 2020].
  • Linares, A., 2017. Ponen bajo la lupa a plaga de orugas venenosas. El Tiempo, 7 Jul, pp. 1–5.
  • Liu, J., et al., 2017. Preparation and neutralization efficacy of IgY antibodies raised against Deinagkistrodon acutus venom. The journal of venomous animals and toxins including tropical diseases, 23, 22.
  • Lucena, S., et al., 2008. The action of Lonomin V (Lonomia achelous) on fibronectin functional properties. Thrombosis research, 121 (5), 653–661.
  • Maranga, L., et al., 2003. Enhancement of Sf-9 cell growth and longevity through supplementation of culture medium with hemolymph. Biotechnology progress, 19 (1), 58–63.
  • Marques, L., 1999. Estudo imonoquimico do veneno da largata lonomia obliqua e desenvolvimento de um ELISA (‘enzyme-linked immunosorbent assay’) para detecção do veneno. Master’s thesis. Universidade Estadual de Campinas (UNICAMP).
  • Mayence, C., et al., 2018. Lonomia caterpillar envenoming in French Guiana reversed by the Brazilian antivenom: a successful case of international cooperation for a rare but deadly tropical hazard. Toxicon, 151, 74–78.
  • Mendonça, R.Z., et al., 2009. Study of kinetic parameters for the production of recombinant rabies virus glycoprotein. Cytotechnology, 60 (1–3), 143–151.
  • Mendonça, R.Z., et al., 2008. Enhancing effect of a protein from Lonomia obliqua hemolymph on recombinant protein production. Cytotechnology, 57 (1), 83–91.
  • Ministerio de Salud y Protección Social., 2014., Resolución 1302. Bogotá, Colombia: Ministerio de Salud y Protección Social.
  • Ministerio de Salud y Protección Social., 2015., Resolución 1241. Bogotá, Colombia: Ministerio de Salud y Protección Social.
  • Ministerio de Salud y Protección Social., 2016., Resolución 1478. Bogotá, Colombia: Ministerio de Salud y Protección Social.
  • Ministerio de Salud y Protección Social, 2017a. Colombia amplía reservas de antídoto contra veneno de oruga. Available from: https://www.minsalud.gov.co/Paginas/Colombia-amplia-reservas-de-antidoto-contra-veneno-de-oruga.aspx [Accessed 24 Mar 2021].
  • Ministerio de Salud y Protección Social., 2017b., Resolución 1209. Bogotá, Colombia: Ministerio de Salud y Protección Social.
  • Ministerio de Salud y Protección Social., 2018., Resolución 1487. Bogotá, Colombia: Ministerio de Salud y Protección Social.
  • Mohamed Abd El-Aziz, Garcia Soares., and Stockand 2019. Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving. Toxins, 11 (10), 564 10.3390/toxins11100564
  • Moher, D., et al., 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine, 6 (7), e1000097.
  • Pardo, L., and Amarillo-Suárez, A., 2018. Modelación de la probabilidad de ocurrencia de accidentes atribuidos a orugas del género Lonomia y descripción de su hábitat en el departamento de Casanare, Colombia. Colombia: Facultad de Estudios Ambientales y Rurales, Pontificia Universidad Javeriana.
  • Pasqualoto, K.F.M., Carrijo-Carvalho, L.C., and Chudzinski-Tavassi, A.M., 2013. Rational development of novel leads from animal secretion based on coagulation and cell targets: 1. In silico analysis to explore a peptide derivative as lipocalins’ signature. Toxicon, 69, 200–210.
  • Peña-Vásquez, W., et al., 2016. Niña con erucismo hemorrágico por Lonomia spp. Revista peruana de medicina experimental y salud publica, 33 (4), 819–823.
  • Perilla-Colmenares, P., and Aldana-Barbosa, R., 2010. Protocolo de vigilancia epidemiologica en salud publica en el departamento de casanare: accidente lonomico. Yopal, Colombia: Secretaria de Salud Departamental.
  • Piñango, C.L., and Guerrero, B., 2003. Síndrome hemorrágico producido por contacto con orugas: estudios clínicos y experimentales: revisión. Investigacion clinica, 44 (2), 155–163.
  • Pineda, D., et al., 2001. Síndrome hemorrágico por contacto con orugas del género Lonomia (Saturniidae) en Casanare, Colombia: informe de dos casos. Biomédica, 21 (4), 328–332.
  • Prezoto, B.C., et al., 2002. Antithrombotic effect of Lonomia obliqua caterpillar bristle extract on experimental venous thrombosis. Brazilian journal of medical and biological research, 35 (6), 703–712.
  • Quintana, M.A., et al., 2017. Stinging caterpillars from the genera Podalia, Leucanella and Lonomia in Misiones, Argentina: a preliminary comparative approach to understand their toxicity. Comparative biochemistry and physiology, 202, 55–62.
  • Raffoul, T., et al., 2005. Performance evaluation of CHO-K1 cell in culture medium supplemented with hemolymph. Brazilian archives of biology and technology, 48 (SPE), 85–95.
  • Redacción El Tiempo., 2001. A la caza de la oruga venenosa. El Tiempo, 31 Aug, 1–3.
  • Redacción, P.M.D., 2018. Alertan por un churrusco más peligroso que la víbora. Periodico del Meta, 2 Jun.
  • Reis, C.V., et al., 2006. Lopap, a prothrombin activator from Lonomia obliqua belonging to the lipocalin family: recombinant production, biochemical characterization and structure-function insights. The Biochemical Journal, 398 (2), 295–302.
  • Rocha-Campos, A.C.M., et al., 2001. Specific heterologous F(ab’)2 antibodies revert blood incoagulability resulting from envenoming by Lonomia obliqua caterpillars. The American journal of tropical medicine and hygiene, 64 (5–6), 283–289.
  • Sánchez, M.N., et al., 2015. Accidentes causados por la oruga Lonomia obliqua (Walker, 1855): un problema emergente. Medicina, 75 (5), 328–333.
  • Sano-Martins, I.S., et al., 2018. Effectiveness of Lonomia antivenom in recovery from the coagulopathy induced by Lonomia orientoandensis and Lonomia casanarensis caterpillars in rats. PLoS Neglected Tropical Diseases, 12 (8), e0006721.
  • Sato, A.C., et al., 2016. Exploring the in vivo wound healing effects of a recombinant hemolin from the caterpillar Lonomia obliqua. The journal of venomous animals and toxins including tropical diseases, 22, 36.
  • Seabrooks, L., and Hu, L., 2017. Insects: an underrepresented resource for the discovery of biologically active natural products. Acta Pharmaceutica Sinica B, 7 (4), 409–426. doi: 10.1016/j.apsb.2017.05.001
  • Sousa, Á.P., Moraes, R.H., and Mendonça, R.Z., 2015. Improved replication of the baculovirus Anticarsia gemmatalis nucleopolyhedrovirus (AgMNPV) in vitro using proteins from Lonomia obliqua hemolymph. Cytotechnology, 67 (2), 331–342.
  • Souza, A.P., et al., 2005. Purification and characterization of an anti-apoptotic protein isolated from Lonomia obliqua hemolymph. Biotechnology progress, 21 (1), 99–105.
  • Tamimi, N.A., and Ellis, P., 2009. Drug development: from concept to marketing!. Nephron clinical practice, 113 (3), c125–c131.
  • Veiga, A.B.G., et al., 2005. A catalog for the transcripts from the venomous structures of the caterpillar Lonomia obliqua: identification of the proteins potentially involved in the coagulation disorder and hemorrhagic syndrome. Gene, 355, 11–27.
  • Vieira, H.L., et al., 2010. Improvement of recombinant protein production by an anti-apoptotic protein from hemolymph of Lonomia obliqua. Cytotechnology, 62 (6), 547–555.
  • Waismam, K., et al., 2009. Lopap: a non-inflammatory and cytoprotective molecule in neutrophils and endothelial cells. Toxicon, 53 (6), 652–659.
  • Yunker, C.E., Vaughn, J.L., and Cory, J., 1967. Adaptation of an insect cell line (Grace’s Antheraea cells) to medium free of insect hemolymph. Science, 155 (3769), 1565–1566.
  • Zamboni, C.B., et al., 2019. Multielemental analyses of Lonomia obliqua (Lepidoptera, Saturniidae) caterpillar using EDXRF and INAA techniques. X-Ray spectrometry, 48 (5), 465–475.
  • Zarbin, P.H., et al., 2007. Sex pheromone of Lonomia obliqua: daily rhythm of production, identification, and synthesis. Journal of chemical ecology, 33 (3), 555–565.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.